CeriBell, Inc. (NASDAQ:CBLL) Given Consensus Recommendation of “Moderate Buy” by Brokerages

Shares of CeriBell, Inc. (NASDAQ:CBLL) have been given an average rating of “Moderate Buy” by the seven brokerages that are covering the firm, MarketBeat reports. One analyst has rated the stock with a sell rating, five have given a buy rating and one has given a strong buy rating to the company. The average 1 year price objective among brokerages that have issued a report on the stock in the last year is $24.6667.

A number of research analysts have recently commented on the company. BTIG Research reiterated a “buy” rating and issued a $30.00 price objective on shares of CeriBell in a report on Wednesday, January 28th. TD Cowen restated a “buy” rating on shares of CeriBell in a report on Tuesday, December 9th. Weiss Ratings reiterated a “sell (e+)” rating on shares of CeriBell in a research note on Wednesday, October 8th. JPMorgan Chase & Co. decreased their price objective on shares of CeriBell from $21.00 to $17.00 and set an “overweight” rating for the company in a research note on Wednesday, November 5th. Finally, Raymond James Financial started coverage on CeriBell in a research report on Tuesday, October 21st. They set a “strong-buy” rating and a $19.00 target price on the stock.

Insider Buying and Selling

In related news, Director Rebecca B. Robertson sold 2,500 shares of the stock in a transaction on Friday, January 2nd. The shares were sold at an average price of $21.89, for a total transaction of $54,725.00. Following the completion of the sale, the director owned 19,576 shares in the company, valued at $428,518.64. This represents a 11.32% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, CEO Xingjuan Chao sold 79,000 shares of CeriBell stock in a transaction on Monday, January 5th. The shares were sold at an average price of $21.27, for a total transaction of $1,680,330.00. Following the completion of the transaction, the chief executive officer owned 741,248 shares in the company, valued at approximately $15,766,344.96. This represents a 9.63% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold 375,212 shares of company stock valued at $7,306,950 in the last 90 days. Company insiders own 20.10% of the company’s stock.

Institutional Trading of CeriBell

Institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Zurcher Kantonalbank Zurich Cantonalbank acquired a new stake in CeriBell during the 3rd quarter worth approximately $33,000. CWM LLC lifted its holdings in shares of CeriBell by 1,178.5% during the fourth quarter. CWM LLC now owns 1,841 shares of the company’s stock worth $40,000 after purchasing an additional 1,697 shares during the period. Tower Research Capital LLC TRC grew its position in CeriBell by 353.8% in the 2nd quarter. Tower Research Capital LLC TRC now owns 2,310 shares of the company’s stock valued at $43,000 after buying an additional 1,801 shares during the last quarter. Ameritas Investment Partners Inc. increased its stake in CeriBell by 97.5% in the 2nd quarter. Ameritas Investment Partners Inc. now owns 2,544 shares of the company’s stock valued at $48,000 after buying an additional 1,256 shares during the period. Finally, Police & Firemen s Retirement System of New Jersey raised its position in CeriBell by 161.0% during the 2nd quarter. Police & Firemen s Retirement System of New Jersey now owns 5,677 shares of the company’s stock worth $106,000 after buying an additional 3,502 shares during the last quarter.

CeriBell Stock Down 1.6%

Shares of NASDAQ:CBLL opened at $20.15 on Thursday. CeriBell has a fifty-two week low of $10.01 and a fifty-two week high of $26.04. The firm’s 50 day moving average price is $21.05 and its 200 day moving average price is $15.62. The company has a quick ratio of 12.25, a current ratio of 12.65 and a debt-to-equity ratio of 0.12. The stock has a market cap of $747.48 million, a price-to-earnings ratio of -13.34 and a beta of 1.03.

CeriBell (NASDAQ:CBLL) last posted its quarterly earnings results on Tuesday, November 4th. The company reported ($0.37) EPS for the quarter, topping the consensus estimate of ($0.43) by $0.06. The company had revenue of $22.59 million during the quarter, compared to analysts’ expectations of $21.78 million. CeriBell had a negative net margin of 63.35% and a negative return on equity of 29.63%. As a group, equities research analysts predict that CeriBell will post -2.46 earnings per share for the current fiscal year.

CeriBell Company Profile

CeriBell Corp (NASDAQ: CBLL) is a healthcare technology company specializing in the design, manufacture and sale of automated newborn hearing screening devices. The company offers a suite of medical diagnostic tools based on otoacoustic emissions (OAE) and auditory brainstem response (ABR) technologies, enabling early detection of auditory impairments in infants. CeriBell’s solutions are used in hospitals, birthing centers and audiology clinics to support universal newborn hearing screening programs aimed at improving language development outcomes through prompt intervention.

The company’s product portfolio includes handheld and desktop screening units, proprietary software for data management, and accessories designed to streamline testing workflows.